Kyowa Hakko, one of Japan’s leading pharmaceutical and food ingredients companies, will highlight the advantages of using cholesterol-lowering CSPHP soy peptide as a functional food ingredient at the International Food Technologists Expo in New Orleans June 23-27.

Kyowa Hakko will make its presentation in Room 288 on Sunday, June 24 from 9:00 am and will focus on how CSPHP’s stability, heat-resistance, and pH-neutral properties make it one of the best ingredients for functional foods that lower cholesterol. CSPHP will be on display at Kyowa Hakko’s booth throughout the event.

The IFT Expo is the world’s largest food industry exposition, attended by thousands of key food industry producers, suppliers, and executives, and is the perfect place for Kyowa Hakko to introduce clinical and stability data about CSPHP soy peptide.

About CSPHP soy peptide — By combining soy protein hydrolyzate with phospholipids, CSPHP soy peptide enhances the natural, soy-reducing properties of soy.

CSPHP soy peptide was included in Choleste Block, a powdered drink that went on sale in Japan since last February 2001 and which is acknowledged by Japan’s Ministry of Health, Labor and Welfare to be a Food for Specified Health Use.

Kyowa studies have shown that a 3-gram dose of CSPHP taken daily for one month reduced LDL-cholesterol by 17 percent, making it a far more effective way to lower LDL-cholesterol than regular soy, 25 grams of which taken at the same rate, only reduces cholesterol 10 percent. The same dosage of CSPHP increased HDL-cholesterol by 14 percent.

About Kyowa Hakko — World leaders in fermentation, biotechnology, and chemical synthesis, Kyowa Hakko develops, manufactures and markets pharmaceuticals, amino acids, nucleic acids, fine chemicals, and food ingredients. Backed by more than half a century of manufacturing innovation, advanced technology, and a commitment to research, Kyowa Hakko’s products are known for high quality, reliability and cost-effectiveness.